NCT07032428

Brief Summary

The goal of this proposal is to provide a first assessment of the efficacy of our innovative non-invasive brain stimulation system, kTMP, in the treatment of anhedonia in MDD.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
22mo left

Started Jul 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jul 2026Jul 2028

First Submitted

Initial submission to the registry

June 14, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

July 15, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2028

Last Updated

July 8, 2026

Status Verified

July 1, 2026

Enrollment Period

2 years

First QC Date

June 14, 2025

Last Update Submit

July 6, 2026

Conditions

Keywords

kTMPNIBSanhedoniaMajor Depressive DisorderCortical ExcitabilityPlasticityNeurosciencereward networkkilohertz Transcranial Magnetic Perturbation

Outcome Measures

Primary Outcomes (2)

  • Ventral striatal BOLD response during reward anticipation

    To assess ventral striatal activation during reward anticipation, patients will participate in a Monetary Incentive Delay (MID) task while in an MRI scanner. We will measure the change in BOLD response during reward anticipation trials, comparing active and sham kTMP and the parametric effect of kTMP on the BOLD response.

    2 months

  • The relationship between the level of ventral striatal engagement and clinical scores of anhedonia

    For each patient, we will obtain the Snaith-Hamilton Pleasure Scale (SHAPS) scores and carry out a multiple regression analysis

    2 months

Secondary Outcomes (11)

  • Changes in scores of the Snaith-Hamilton Pleasure Scale (SHAPS).

    6 months

  • The response bias in the Probabilistic Reward Task (PRT).

    6 months

  • The motivation to pursue reward in the Effort Expenditure for Rewards Task (EEfRT).

    6 months

  • Scores in the Visual Analog Scale of Anhedonia (VAS).

    6 months

  • Scores in the Temporal Experience of Pleasure Scale (TEPS).

    6 months

  • +6 more secondary outcomes

Study Arms (2)

Active kTMP

EXPERIMENTAL

Participants received 8 V/m of active stimulation

Device: A new non-invasive brain stimulation tool

Sham kTMP

SHAM COMPARATOR

Participants received 0.0 V/m of sham stimulation

Device: A new non-invasive brain stimulation tool with sham setting selected

Interventions

kTMP is a magnetic induction method that delivers continuous kHz-frequency cortical electric fields (E-fields) which may be amplitude-modulated to potentially mimic electrical activity at endogenous frequencies which will be tested on anhedonia patients in this study.

Active kTMP

This device will counterbalance the active kTMP conditions

Sham kTMP

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

AnhedoniaDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsDepressive DisorderMood DisordersMental Disorders

Central Study Contacts

Christina Merrick

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2025

First Posted

June 24, 2025

Study Start

July 15, 2026

Primary Completion (Estimated)

July 30, 2028

Study Completion (Estimated)

July 30, 2028

Last Updated

July 8, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share